PubMed

Management of progressive type 2 diabetes: role of insulin therapy.

Chemitiganti RR, Spellman CW.

Osteopath Med Prim Care. 2009 Jul 2;3:5.PMID: 19573240 [PubMed - in process]Free PMC ArticleFree textRelated citations

Effects of initiating insulin and metformin on glycemic control and inflammatory biomarkers among patients with type 2 diabetes: the LANCET randomized trial.

Pradhan AD, Everett BM, Cook NR, Rifai N, Ridker PM.

JAMA. 2009 Sep 16;302(11):1186-94.PMID: 19755697 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Future therapeutic directions; new medications and insulin delivery in a changing world for effective diabetes management.

Modi P.

Curr Drug Discov Technol. 2009 Sep;6(3):200-13. Epub 2009 Sep 1. Review.PMID: 19496750 [PubMed - indexed for MEDLINE]Related citations

The consequences of delaying insulin initiation in UK type 2 diabetes patients failing oral hyperglycaemic agents: a modelling study.

Goodall G, Sarpong EM, Hayes C, Valentine WJ.

BMC Endocr Disord. 2009 Oct 5;9:19.PMID: 19804622 [PubMed]Free PMC ArticleFree textRelated citations

The role of insulin detemir in overweight type 2 diabetes management.

Demssie YN, Younis N, Soran H.

Vasc Health Risk Manag. 2009;5(3):553-60. Epub 2009 Jun 29. Review.PMID: 19590589 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Defining the importance of daily glycemic control and implications for type 2 diabetes management.

Bode BW.

Postgrad Med. 2009 Sep;121(5):82-93. Review.PMID: 19820277 [PubMed - indexed for MEDLINE]Related citations

Patterns of youths' glycemic control with insulin pump therapy.

Nelson A, Genthe JA, Gall KM, Edwards E.

Pediatr Nurs. 2009 Jul-Aug;35(4):234-9.PMID: 19785303 [PubMed - indexed for MEDLINE]Related citations

Exenatide added to insulin therapy: a retrospective review of clinical practice over two years in an academic endocrinology outpatient setting.

Yoon NM, Cavaghan MK, Brunelle RL, Roach P.

Clin Ther. 2009 Jul;31(7):1511-23.PMID: 19695400 [PubMed - indexed for MEDLINE]Related citations

Type 2 diabetes: where we are today: an overview of disease burden, current treatments, and treatment strategies.

Campbell RK.

J Am Pharm Assoc (2003). 2009 Sep-Oct;49 Suppl 1:S3-9. Review.PMID: 19801365 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

[Exenatide trials for the treatment of type 2 diabetes]

Fernández Landó L, Casellini CM.

Medicina (B Aires). 2009;69(4):447-57. Spanish. PMID: 19770100 [PubMed - in process]Related citations

Beyond glycemic control: treating the entire type 2 diabetes disorder.

Brunton S.

Postgrad Med. 2009 Sep;121(5):68-81. Review.PMID: 19820276 [PubMed - indexed for MEDLINE]Related citations

Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.

Wenying Y, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Ligthelm R, Valensi P; IMPROVE Study Group Expert Panel.

Curr Med Res Opin. 2009 Nov;25(11):2643-54.PMID: 19751116 [PubMed - indexed for MEDLINE]Related citations

Fate of the beta-cell in the pathophysiology of type 2 diabetes.

Campbell RK.

J Am Pharm Assoc (2003). 2009 Sep-Oct;49 Suppl 1:S10-5. Review.PMID: 19801360 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Redefining insulin therapy in type 2 diabetes mellitus.

Rosenstock J.

Postgrad Med. 2004 Nov;116(5 Suppl Exploring):21-9.PMID: 19667676 [PubMed - indexed for MEDLINE]Related citations

Perioperative management of diabetes: translating evidence into practice.

Meneghini LF.

Cleve Clin J Med. 2009 Nov;76 Suppl 4:S53-9.PMID: 19880837 [PubMed - in process]Free ArticleRelated citations

Risk for nocturnal hypoglycemia with biphasic insulin aspart 30 compared with biphasic human insulin 30 in adults with type 2 diabetes mellitus: a meta-analysis.

Davidson JA, Liebl A, Christiansen JS, Fulcher G, Ligthelm RJ, Brown P, Gylvin T, Kawamori R.

Clin Ther. 2009 Aug;31(8):1641-51.PMID: 19808125 [PubMed - indexed for MEDLINE]Related citations

[Cross-sectional epidemiological study of clinical profiles and glycemic control in diabetic patients in primary care in Spain (the EPIDIAP study)]

de Pablos Velasco P, Franch J, Banegas Banegas JR, Fernández Anaya S, Sicras Mainar A, Díaz Cerezo S.

Endocrinol Nutr. 2009 May;56(5):233-40. Epub 2009 Jul 1. Spanish. Erratum in: Endocrinol Nutr. 2009 Jun-Jul;56(6):330. PMID: 19627744 [PubMed - indexed for MEDLINE]Related citations

Exenatide versus insulin glargine: a cost-effectiveness evaluation in patients with Type 2 diabetes in Switzerland.

Brändle M, Erny-Albrecht KM, Goodall G, Spinas GA, Streit P, Valentine WJ.

Int J Clin Pharmacol Ther. 2009 Aug;47(8):501-15.PMID: 19640359 [PubMed - indexed for MEDLINE]Related citations

New insights into myocardial glucose metabolism: surviving under stress.

Patterson B, Fields AV, Shannon RP.

Curr Opin Clin Nutr Metab Care. 2009 Jul;12(4):424-30. Review.PMID: 19494769 [PubMed - indexed for MEDLINE]Related citations

A review of exenatide as adjunctive therapy in patients with type 2 diabetes.

Robles GI, Singh-Franco D.

Drug Des Devel Ther. 2009 Sep 21;3:219-40.PMID: 19920937 [PubMed - in process]Free PMC ArticleFree textRelated citations